Scientists developed the first ‘Made in India’ completely indigenous vaccine to prevent severe rotavirus diarrhoea, which kills more than one lakh children under the age of five in India every year.
Indian pharmaceutical major, Piramal Enterprises had received approval from US health regulator USDFA for its new anti-diabetic drug
Arvind Remedies Ltd, a leading producer of Branded and Generic pharmaceutical products, participated in the National Workshop and Industry-Academia meet on Drugs and Pharmaceuticals, Research and Development organised by the Department of Biotechnology, Pondicherry University and the Department of Science and Technology, Government of India, recently.
Orchid Pharmaceuticals forges alliance with Europe based venture capital funded Allecra Therapeutics to develop antibiotics to combat multi-drug resistant bacterial infections
Dr Reddy’s Laboratories Limited has successfully launched Zoledronic Acid Injection, used for treating osteoporosis and Paget's disease of bone in the US market following approval from the US health regulator.
Aurobindo Pharma Ltd gets nod from the US Food & Drug Administration (USFDA) to manufacture and market its anti-AIDS combination drug Efavirenz/ Emtricitabine and Tenofovir Disoproxil Fumarate Tablets.
The Supreme Court of India dismissed the Swiss drug manufacturer, Novartis AG's appeal for patent protection of its anti-cancer drug, Gilvec thus putting an end to a seven year battle between Novartis and several domestic generic drug makers, as well as patient groups fighting for affordable medicines.
Dr Reddy’s Laboratories launch Zometa generic injection in US market
Informatica Corporation, world’s number one independent provider of data integration software, introduced Informatica Healthcare Data Management in India yesterday.
Sankara Nethralaya has signed an agreement with Sri City to set up eye care hospital and research facility to benefit thousands of patients in the region.
GlaxoSmithKline Pharmaceuticals has reported a 1.29 per cent rise in its net profit at Rs 138.51 crore for the quarter ended December 31, 2012
Healthcare service provider Aventis Pharma which is now called as Sanofi India introduces new product Combiflam plus for headache
Biocon join hands with American generic drugmaker Mylan for developing and marketing generic versions of three high-value insulin products for developed and emerging markets
Biocon, a biotechnology firm in India has forged a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products.
Fortis Healthcare has posted a profit of Rs 705 crore in the third quarter of 2012-13, as its strategy of selling its stake in Religare Health Trust pays off.
